Ciliatech

Healthcare SpecialistsSeries AFrancecilia.tech

Latest round

Series A

Last raised

Apr 2023

Total raised

$3.1M

Investors

3

About Ciliatech

Based in France, and founded in 2017 by co-founders Philippe Sourdille and Olivier Benoit, Ciliatech offers cilia-scleral inter-positioning device technology that treats open-angle glaucoma. The accumulation of aqueous humor, fluid in the eye, leads to glaucoma. This causes the intraocular pressure (IOP) to increase, which damages the optic nerve and leads to vision loss. The company developed the CID (Cilio-Scleral Inter-positioning Device) to effectively reduce intraocular pressure (IOP) without penetrating the anterior chamber or creating subconjunctival filtration critical measures, enabling eye surgeons to overcome the complications and shortcomings of other glaucoma surgical techniques. This offers the unparalleled advantage of unlocking the natural uveoscleral pathway while leaving the anterior chamber fully intact, along with the wall that separates it from the supraciliary space.

Who invested in Ciliatech

3 investors across 3 rounds

See all investors in Ciliatech

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series A

    Apr 25, 2023

    Amount

    $1.9M

    Investors

    Locked

  2. Series B

    Sep 27, 2021

    Amount

    $0.6M

    Investors

    Locked

  3. Series B

    May 2, 2018

    Amount

    $0.6M

    Investors

    Locked

Questions about Ciliatech

Who invested in Ciliatech?

Ciliatech has 3 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Ciliatech raised?

Ciliatech has raised 3 venture rounds. Sign up free to see how much each round raised and the total.

When did Ciliatech last raise money?

Ciliatech's most recent round on record is a Series A, in Apr 2023.

What does Ciliatech do?

Based in France, and founded in 2017 by co-founders Philippe Sourdille and Olivier Benoit, Ciliatech offers cilia-scleral inter-positioning device technology that treats open-angle glaucoma.

Where is Ciliatech headquartered?

Ciliatech is headquartered in France.

Which VCs invest in companies like Ciliatech?

Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back healthcare specialists companies at Ciliatech's stage. Their profiles are linked below.

Raising like Ciliatech? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.